Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis

  • 11k

    Total Downloads

  • 39k

    Total Views and Downloads

Articles

CLINICAL TRIAL

Published on 16 Mar 2021

A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)

  • Daniel Heudobler
  • Christian Schulz
  • Jürgen R. Fischer
  • Peter Staib
  • Thomas Wehler
  • Thomas Südhoff
  • Thomas Schichtl
  • Jochen Wilke
  • Joachim Hahn
  • 8 more
  • Albrecht Reichle
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)
doi 10.3389/fphar.2021.599598
  • 2,805 views
  • 10 citations